Latest Rhinitis Stories
OXFORD, England, May 13 /PRNewswire/ -- Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced that it has initiated a phase II clinical development programme for its ragweed allergy therapy.
LEEDS and LONDON, May 11 /PRNewswire/ -- - New Hayfever Relief Product Based on Acupressure Points Now Available in UK Stores & Widely Available on the Internet - With Photo Hayfever was unheard of only 200 years ago, however, it's believed that it now affects as many as 1 in 4 people in the UK.
Neti Pots Show Increase In Searches, Social Media "Chatter," As Consumers Seek Protection Ideas Above and Beyond CDC Recommendations MADISON, Wis., May 4 /PRNewswire/ -- Add nose washing to the steps that consumers are looking to take -- in addition to frequent hand washing and coughing in a tissue -- in an effort to avoid infection with the flu. According to data from Google Insights For Search, "neti pot" increased as a search term some 15-20% last week, with New York and California in...
ANTONY, France, April 29 /PRNewswire-FirstCall/ -- Stallergenes S.A. announces the release of the first year outcome of its phase IIb/III clinical trial (VO 57.07) on a sublingual house dust mite desensitization tablet. "We are very pleased with the outcome of this study, which is the first large study to ever demonstrate the efficacy of house dust mites allergen in treating perennial allergic rhinitis.
Children with allergies and asthma may benefit from an allergy evaluation, a U.S. allergist advises. Dr.
OXFORD, England, April 21 /PRNewswire/ -- Circassia Ltd, a specialty biopharmaceutical company focused on allergy, announced today that it has initiated a phase II clinical study of its ToleroMune(R) technology in allergy patients with asthma.
First Selective TLR8 Agonist to Advance for Treatment of Allergy SAN DIEGO, April 16 /PRNewswire/ -- VentiRx Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of novel Toll-Like Receptor 8 (TLR8) agonists for the treatment of cancer, respiratory and inflammatory diseases, announced today that it has initiated a Phase I clinical trial of VTX-1463, a selective intranasal TLR8 agonist for the treatment of allergic rhinitis.
- TV Host Explains How Talking to a Pharmacist Helped Her Manage Her Congestion so She Can Get Back to Her Busy Schedule - WASHINGTON, D.C., April 2 /PRNewswire/ -- Mom, actress and allergy sufferer Alison Sweeney knows first hand how symptoms like congestion can make juggling a busy career and family life even more challenging.
Alleviating springtime allergies begins with avoiding pollen, if possible, a U.S. doctor advises. Dr. Catherine Monteleone, a board-certified allergist at the University of Medicine and Dentistry of New Jersey, suggests keeping car and home windows closed and, if necessary, the air conditioner on.
IRVINGTON, N.Y., March 11 /PRNewswire/ -- Spring has sprung and with it arrives the onset of unrelenting allergy symptoms which for many, will persist throughout the season into summer. For over 40 million Americans in search of allergy relief this season, a solution can't come fast enough.
- A poem in which the author retracts something said in an earlier poem.